Novoimmune
Jun 13, 2019
Telegenomics nets $23M; Merck acquires Tilos; ADC nabs; Sobi buys Novoimmune’s assets
Telegenomics Company Genome Medical nets USD 23 M Genome Medical, a telegenomics company, having expertise in delivering genome-based medicine has raised USD 23 Million in series B funding. The proceeds will be used by the company to accelerate the development of its technology and medical services to supp...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
